The experiment found that a modified analogue of vitamin B12 known as nitrosylcobalamin (NO-Cbl) that was specifically designed to include nitric oxide, a substance that can kill tumour cells selectively, managed to pass the blood-brain barrier. While the research looks promising, there is still a long way to go before it can be applied to patients
The experiment found that a modified analogue of vitamin B12 known as nitrosylcobalamin (NO-Cbl) that was specifically designed to include nitric oxide, a substance that can kill tumour cells selectively, managed to pass the blood-brain barrier. While the research looks promising, there is still a long way to go before it can be applied to patients
<iframe src="https://hindustansphere.com/embed/cluster/df03cba3173b96c45b2fd8e392f14d24a3a132b3" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="What does the new research on Vitamin B12-based therapy for brain cancer reveal?"></iframe>
The experiment found that a modified analogue of vitamin B12 known as nitrosylcobalamin (NO-Cbl) that was specifically designed to include nitric oxide, a substance that can kill tumour cells selectively, managed to pass the blood-brain barrier. While the research looks promising, there is still a long way to go before it can be applied to patients
